Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
Open accessThe DOI matches its Crossref record; 44 of the 46 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The interrogation of proteomes ("proteomics") in a highly multiplexed and efficient manner remains a coveted and challenging goal in biology and medicine. METHODOLOGY/PRINCIPAL FINDINGS: We present a new aptamer-based proteomic technology for biomarker discovery capable of simultaneously measuring thousands of proteins from small sample volumes (15 µL of serum or plasma). Our current assay measures 813 proteins with low limits of detection (1 pM median), 7 logs of overall dynamic range (~100 fM-1 µM), and 5% median coefficient of variation. This technology is enabled by a new generation of aptamers that contain chemically modified nucleotides, which greatly expand the physicochemical diversity of the large randomized nucleic acid libraries from which the aptamers are selected. Proteins in complex matrices such as plasma are measured with a process that transforms a signature of protein concentrations into a corresponding signature of DNA aptamer concentrations, which is quantified on a DNA microarray. Our assay takes advantage of the dual nature of aptamers as both folded protein-binding entities with defined shapes and unique nucleotide sequences recognizable by specific hybridization probes. To demonstrate the utility of our proteomics biomarker discovery technology, we applied it to a clinical study of chronic kidney disease (CKD). We identified two well known CKD biomarkers as well as an additional 58 potential CKD biomarkers. These results demonstrate the potential utility of our technology to rapidly discover unique protein signatures characteristic of various disease states. CONCLUSIONS/SIGNIFICANCE: We describe a versatile and powerful tool that allows large-scale comparison of proteome profiles among discrete populations. This unbiased and highly multiplexed search engine will enable the discovery of novel biomarkers in a manner that is unencumbered by our incomplete knowledge of biology, thereby helping to advance the next generation of evidence-based medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures













Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Major developments in mass spectrometry-based, antibody-based and aptamer-based proteomics over the past decade have enabled the robust quantification of thousands of proteins in single samples87–90.”
From Measuring biological age using omics data (2022) · cites this paper as [89]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The assay uses DNA-based slow off-rate modified aptamers (SOMAmerTM reagents) to quantify the relative abundance of approximately 7000 proteins with high specificity and limits of detection largely comparable to antibody-based assays.”
From Cross-ancestry comparison of aptamer and antibody protein measures (2026) · cites this paper as [53]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Proteomic technologies, including mass spectrometry–based proteomics, aptamer-based arrays (SomaLogic), and proximity extension assay technology (Olink), are now available for the large-scale quantification and validation of thousands of proteins in human biological fluids or tissues (122–127).”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RNA-Mediated Metal-Metal Bond Formation in the Synthesis of Hexagonal Palladium Nanoparticles
Gugliotti, L. A., Feldheim, D. L., & Eaton, B. E. (2004) · Science · doi:10.1126/science.1095678 · Cited by 197 · cited 2×
“This innovation was used to select catalysts, including the first RNA-catalyzed carbon-carbon bond formation [16,23].”
MethodSelf-citationRetractedLevey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Tuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,405 · cited 4×
“Based on the collective knowledge of the aptamer field that has developed since its inception [13,14], we hypothesized that aptamers could make exceptional reagents for high-content proteomics.”
BackgroundInfluentialSelf-citationIn vitro selection of RNA molecules that bind specific ligands
Ellington, A. D., & Szostak, J. W. (1990) · Nature · doi:10.1038/346818a0 · Cited by 9,812 · cited 4×
“Based on the collective knowledge of the aptamer field that has developed since its inception [13,14], we hypothesized that aptamers could make exceptional reagents for high-content proteomics.”
BackgroundInfluentialKeller, A., Nesvizhskii, A. I., Kolker, E., & Aebersold, R. (2002) · Analytical Chemistry · doi:10.1021/ac025747h · Cited by 4,830 · cited 2×
“0% probability as specified by the Peptide Prophet algorithm [45].”
MethodA Statistical Model for Identifying Proteins by Tandem Mass Spectrometry
Nesvizhskii, A. I., Keller, A., Kolker, E., & Aebersold, R. (2003) · Analytical Chemistry · doi:10.1021/ac0341261 · Cited by 4,809 · cited 3×
“Protein probabilities were assigned by the Protein Prophet algorithm [44].”
MethodAssessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
Stevens, L. A., Coresh, J., Greene, T., & Levey, A. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054415 · Cited by 2,952 · cited 2×
“Eleven subjects had early-stage CKD based on estimated GFR (Table 3) (eGFR, defined as stages 1–2, median creatinine clearance 70 ml/min/m, range 62–97 ml/min/m) and 31 had late-stage CKD (stages 3–5, median creatinine clearance 25 ml/min/m, range 7–49 ml/min/m) [33].”
BackgroundPegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337 · cited 1×
“Aptamers are a class of nucleic acid-based molecules discovered twenty years ago [13,14] and have since been employed in diverse applications including therapeutics [15], catalysis [16], and now proteomics.”
BackgroundHopfield, J. J. (1974) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.71.10.4135 · Cited by 1,594 · cited 2×
“Inspired by classic kinetic theory of specific binding in complex mixtures [25,26], we employed kinetic manipulations to help overcome the problem of non-specific SOMAmer-protein binding.”
MethodLevey, A. S., Atkins, R., Coresh, J., Cohen, E. P., Collins, A. J., Eckardt, K.-U., Nahas, M. E., Jaber, B. L., Jadoul, M., Levin, A., et al. (2007) · Kidney International · doi:10.1038/sj.ki.5002343 · Cited by 1,516 · cited 4×
“CKD biomarkers could also be useful for monitoring disease progression and guiding treatment [28–31].”
BackgroundInfluential
Cited by
Items 901–1,000 of 1,009
Prediction of late-onset preeclampsia using plasma proteomics: a longitudinal multi-cohort study
Andresen, I. J., Zucknick, M., Degnes, M.-H. L., Angst, M. S., Aghaeepour, N., Romero, R. J., Roland, M. C. P., Tarca, A. L., Westerberg, A. C., & Michelsen, T. M. (2024) · Scientific Reports · doi:10.1038/s41598-024-81277-2 · Cited by 21
Integrated liver-secreted and plasma proteomics identify a predictive model that stratifies MASH
Nardo, W. D., Lee, O., Johari, Y., Bayliss, J. A., Pensa, M., Miotto, P. M., Keenan, S. N., Ryan, A., Rucinski, A., Svinos, T. M., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102085 · Cited by 24
Nucleic Acid Aptamers Targeting Epigenetic Regulators: An Innovative Therapeutic Option
Catuogno, S., Esposito, C. L., Ungaro, P., & de Franciscis, V. (2018) · Pharmaceuticals · doi:10.3390/ph11030079 · Cited by 14
Trypsin enhances aptamer screening: A novel method for targeting proteins
Gu, L., Yan, W., Liu, S., Ren, W., Lyu, M., & Wang, S. (2018) · Analytical Biochemistry · doi:10.1016/j.ab.2018.09.004 · Cited by 14
Liu, C., Jiang, W., Tian, X., Yang, P. H., Xiao, L., Li, J., Qiu, L., Tu, H., & Tan, W. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b00609 · Cited by 14
Balanced Event Prediction Through Sampled Survival Analysis
Datta, G., Alexander, L. E., Hinterberg, M., & Hagar, Y. (2019) · Systems Medicine · doi:10.1089/sysm.2018.0015 · Cited by 17
Mueller, S. K., Nocera, A. L., Workman, A. D., Libermann, T. A., Dillon, S. T., Stegmann, A., Wurm, J., Iro, H., Wendler, O., & Bleier, B. S. (2020) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22512 · Cited by 16
Integrating Genetics and the Plasma Proteome to Predict the Risk of Type 2 Diabetes
Carrasco-Zanini, J., Pietzner, M., & Langenberg, C. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-01340-w · Cited by 15
Functional Network Profiles in ARSACS Disclosed by Aptamer-Based Proteomic Technology
Morani, F., Doccini, S., Chiorino, G., Fattori, F., Galatolo, D., Sciarrillo, E., Gemignani, F., Zuchner, S. L., Bertini, E., & Santorelli, F. M. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.603774 · Cited by 16
“We used SOMAscan, a new aptamerbased proteomics assay that, by means of innovative and specific SOMAmer-based DNA signals, can quantitatively detect proteins in biological samples up to femtomolar concentration (7, 8).”
MethodTracz, J., & Łuczak, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147492 · Cited by 14
Proteomics in thrombosis research
Edfors, F., Iglesias, M. J., Butler, L. M., & Odeberg, J. (2022) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12706 · Cited by 16
Practical Synthesis of Cytidine-5-Carboxamide-Modified Nucleotide Reagents
Rohloff, J. C., Fowler, C. R., Ream, B. E., Carter, J. D., Wardle, G. S., & Fitzwater, T. (2015) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2014.978011 · Cited by 14
Self-citationChudinov, A. V., Kiseleva, Y. Y., Kuznetsov, V. E., Shershov, V. E., Spitsyn, M. A., Гусейнов, Т. О., Lapa, S. A., Timofeev, E. N., Archakov, A. I., Lisitsa, A., et al. (2017) · Molecular Biology · doi:10.1134/s0026893317030025 · Cited by 14
Proteomic approaches for novel systemic lupus erythematosus (SLE) drug discovery
Li, Y., & Wu, T. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1480718 · Cited by 14
“To demonstrate the utility of this platform, they piloted a clinical study of chronic kidney disease (CKD).”
BackgroundInfluentialTethered imidazole mediated duplex stabilization and its potential for aptamer stabilization
Verdonck, L., Buyst, D., de Vries, A.-M., Gheerardijn, V., Madder, A., & Martins, J. C. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1062 · Cited by 16
Lapa, S. A., Romashova, K. S., Spitsyn, M. A., Shershov, V. E., Kuznetsova, V. E., Гусейнов, Т. О., Zasedateleva, O. A., Radko, S. P., Timofeev, E. N., Lisitsa, A., et al. (2018) · Molecular Biology · doi:10.1134/s0026893318060110 · Cited by 14
Fine-Mapping of the Human Blood Plasma N-Glycome onto Its Proteome
Suhre, K., Trbojević‐Akmačić, I., Ugrina, I., Mook-Kanamori, D. O., Spector, T. D., Graumann, J., Lauc, G., & Falchi, M. (2019) · Metabolites · doi:10.3390/metabo9070122 · Cited by 13
Mendelian randomization study of interleukin (IL)-1 family and lung cancer
Yang, Z., Schooling, C. M., & Kwok, M. K. (2021) · Scientific Reports · doi:10.1038/s41598-021-97099-5 · Cited by 14
Cross-ancestry comparison of aptamer and antibody protein measures
Nicholas, J. C., Katz, D. H., Tahir, U. A., Debban, C. L., Aguet, F., Blackwell, T., Bowler, R. P., Broadaway, K. A., Chen, J., Clish, C. B., et al. (2026) · Nature Communications · doi:10.1038/s41467-025-67814-1 · Cited by 13
“36 – 53).”
InfluentialSystemic Inflammation and Metabolic Changes After Cardiac Surgery and Postoperative Delirium Risk
Wiredu, K., Qu, J. Z., Turco, I., McKay, T. B., & Akeju, O. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14134600 · Cited by 16
Plasma proteomic analysis identifies proteins and pathways related to Alzheimer's risk
Huang, Y.-N., Liu, S., Park, T., Chaudhuri, S., Kuchenbecker, L. A., Carrasquillo, M. M., Ertekin‐Taner, N., Bice, P. J., Zetterberg, H., Blennow, K., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70579 · Cited by 20
Expanding the chemical repertoire of aptamers
Akhtar, U., He, W., Gasse, C., Tanner, J. A., & Hollenstein, M. (2025) · Trends in Chemistry · doi:10.1016/j.trechm.2025.11.006 · Cited by 16
Acute serum protein and cytokine response of single dose of prednisone in adult volunteers
Roy, R., Soldin, S. J., Stolze, B. R., Barbieri, M. L., Tawalbeh, S. M., Rouhana, N. A., Fronczek, A. E., Nagaraju, K., van den Anker, J. N., Dang, U. J., et al. (2022) · Steroids · doi:10.1016/j.steroids.2021.108953 · Cited by 13
APOL1 Kidney Risk Variants and Proteomics
Chen, T. K., Surapaneni, A. L., Arking, D. E., Ballantyne, C. M., Boerwinkle, E., Chen, J., Coresh, J., Köttgen, A., Suszták, K., Tin, A., et al. (2022) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.14701121 · Cited by 14
Li, S. R., Moheimani, H., Herzig, B., Kail, M., Krishnamoorthi, N., Wu, J., Abdelhamid, S. S., Scioscia, J. P., Sung, E., Rosengart, A., et al. (2023) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000003880 · Cited by 17
“Yes 51 (65) 11 (32) 6 (20) 21 (57) 20 (17)”
Richards, S. M., Guo, F., Zou, H., Nigsch, F., Baiges, A., Pachori, A. S., Zhang, Y., Lens, S., Pitts, R., Finkel, N., et al. (2023) · Liver International · doi:10.1111/liv.15657 · Cited by 13
Candia, J., Fantoni, G., Moaddel, R., Delgado‐Peraza, F., Shehadeh, N., Tanaka, T., & Ferrucci, L. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5c00069 · Cited by 20
Amaya, M., Baer, A., Voss, K., Campbell, C. E., Mueller, C., Bailey, C., Kehn‐Hall, K., Petricoin, E. F., & Narayanan, A. (2014) · Pathogens and Disease · doi:10.1111/2049-632x.12150 · Cited by 13
Aptamer microarray as a novel bioassay for protein–protein interaction discovery and analysis
Chen, L., Tzeng, S., & Peck, K. (2012) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2012.10.082 · Cited by 13
Influence of 5-N-carboxamide modifications on the thermodynamic stability of oligonucleotides
Wolk, S. K., Shoemaker, R. L., Mayfield, W., Mestdagh, A. L., & Janjić, N. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv981 · Cited by 13
Self-citationProtein arrays for biomarker discovery in lupus
Hinchliffe, T. E., Lin, Z., & Wu, T. (2016) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201500060 · Cited by 15
Grigorieva, J., Asmellash, S. G., Oliveira, C., Röder, H., Net, L., & Roder, J. (2019) · Clinical mass spectrometry · doi:10.1016/j.clinms.2019.09.001 · Cited by 16
Proteomic Approaches to Defining Remission and the Risk of Relapse in Rheumatoid Arthritis
O’Neil, L. J., Hu, P., Liu, Q., Islam, M. M., Spicer, V., Rech, J., Hueber, A. J., Anaparti, V., Smolik, I., El-Gabalawy, H. S., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.729681 · Cited by 17
Selection of M2+‐Independent RNA‐Cleaving DNAzymes with Side‐Chains Mimicking Arginine and Lysine
Paul, S., Wong, A. A. W. L., Liu, L. T., & Perrin, D. M. (2021) · ChemBioChem · doi:10.1002/cbic.202100600 · Cited by 13
Zhang, L., Yang, Z., Trinh, T. L., Teng, I., Wang, S., Bradley, K. M., Hoshika, S., Wu, Q., Cansız, S., Rowold, D. J., et al. (2016) · Angewandte Chemie · doi:10.1002/ange.201605058 · Cited by 13
Palà, E., Bustamante, A., Clua‐Espuny, J. L., Acosta, J., González-Loyola, F., Santos, S. D., Ribas-Seguí, D., Ballesta-Ors, J., Peñalba, A., Giralt, M., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0273571 · Cited by 15
Molecular Clusters and Tumor-Immune Drivers of IgM Monoclonal Gammopathies
Mondello, P., Paludo, J., Novak, J. P., Wenzl, K., Yang, Z.-Z., Jalali, S., Krull, J. E., Braggio, E., Dasari, S., Manske, M. K., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-2215 · Cited by 16
Dubin, R. F., Deo, R., Ren, Y., Lee, H., Shou, H., Feldman, H. I., Kimmel, P. L., Waikar, S. S., Rhee, E. P., Tin, A., et al. (2023) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfac145 · Cited by 12
HDL-Associated Proteins in Subjects with Polycystic Ovary Syndrome: A Proteomic Study
Butler, A. E., Moin, A. S. M., Reiner, Ž., Sathyapalan, T., Jamialahmadi, T., Sahebkar, A., & Atkin, S. L. (2023) · Cells · doi:10.3390/cells12060855 · Cited by 18
High Efficiency Acetylcholinesterase Immobilization on DNA Aptamer Modified Surfaces
Chumphukam, O., Le, T., & Cass, A. E. G. (2014) · Molecules · doi:10.3390/molecules19044986 · Cited by 13
Integrating and Mining Diverse Data in Human Immunological Studies
Siebert, J., Wagner, B. D., & Juarez‐Colunga, E. (2014) · Bioanalysis · doi:10.4155/bio.13.309 · Cited by 13
Microfluidic Strategies Applied to Biomarker Discovery and Validation for Multivariate Diagnostics
Tarasow, T. M., Penny, L., Patwardhan, A. J., Hamren, S., McKenna, M. P., & Urdea, M. S. (2011) · Bioanalysis · doi:10.4155/bio.11.224 · Cited by 13
Mass Spectrometry-Based Biomarkers in Drug Development
Robinson, M., Miller, R. A., & Spellman, D. S. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-15950-4_25 · Cited by 13
Modulating the Substrate Selectivity of DNA Aptamers Using Surfactants
Peterson, A. M., Jahnke, F. M., & Heemstra, J. M. (2015) · Langmuir · doi:10.1021/acs.langmuir.5b02818 · Cited by 14
Drug Resistance Assays for Parasitic Diseases
Légaré, D., & Ouellette, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-47266-9_36 · Cited by 16
Targeting Unique Epitopes on Highly Similar Proteins GDF-11 and GDF-8 with Modified DNA Aptamers
Ochsner, U. A., Green, L. S., Rice, T., Olivas, E., Janjić, N., & Katilius, E. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00760 · Cited by 14
Self-citationAutophagy Modulators Profoundly Alter the Astrocyte Cellular Proteome
Sher, A. A., Gao, A., & Coombs, K. M. (2020) · Cells · doi:10.3390/cells9040805 · Cited by 13
Using Aptamers as a Novel Method for Determining GnRH/LH Pulsatility
Izzi‐Engbeaya, C. N., Abbara, A., Cass, A. E. G., & Dhillo, W. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197394 · Cited by 16
Elliott, A., McGonagle, D., & Rooney, M. E. (2021) · Lara D. Veeken · doi:10.1093/rheumatology/keab504 · Cited by 13
Cruchaga, C., Ali, M., Shen, Y., Do, A. N., Wang, L., Western, D., Liu, M., Beric, A., Budde, J., Gentsch, J., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3631708/v1 · Cited by 16
Pine, A. B., Butt, A., Andréoli, L., Knight, J. S., Gerosa, M., Cecchi, I., Branch, D. W., Lopez-Pedrera, R., Belmont, M. H., Kello, N., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1676578 · Cited by 12
Enhancing CAR-T Cell Therapy with Functional Nucleic Acids
Maru, B., Nadeau, L., & McKeague, M. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00188 · Cited by 16
Wittich, H., Ardlie, K., Taylor, K. D., Durda, P., Liu, Y., Mikhaylova, A. V., Gignoux, C. R., Cho, M. H., Rich, S. S., Rotter, J. I., et al. (2024) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2024.01.006 · Cited by 15
Plasma/Serum Proteomics based on Mass Spectrometry
Zhu, Y. (2024) · Protein and Peptide Letters · doi:10.2174/0109298665286952240212053723 · Cited by 18
Kim, H., Chen, J., Prescott, B. R., Walker, M. E., Grams, M. E., Yu, B., Vasan, R. S., Floyd, J. S., Sotoodehnia, N., Smith, N. L., et al. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.07.005 · Cited by 14
Deng, Y., Perry, T. A., Hulley, P. A., Maciewicz, R. A., Mitchelmore, J., Perry, D., Larsson, S., Brachat, S., Struglics, A., Appleton, C. T., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0309677 · Cited by 13
Ceelen, D. C. H., Bračun, V., van Essen, B. J., Voors, A. A., de Boer, R. A., ter Maaten, J. M., Masson, S., Kastner, P., Lang, C. C., & Suthahar, N. (2024) · Heart · doi:10.1136/heartjnl-2024-324486 · Cited by 11
Harkai, Á., Beck, Y. K., Tory, A., & Mészáros, T. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.138579 · Cited by 16
Shaker, S., Li, J., Wan, S., Xuan, H., Long, J., Cao, H., Wei, T., Liu, Q., Xu, D., Benner, S. A., et al. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf072 · Cited by 12
Kuprikova, N. M., Ondruš, M., Bednářová, L., Kraus, T., Slavětínská, L. P., Sýkorová, V., & Hocek, M. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf155 · Cited by 12
Human plasma proteomic profile of clonal hematopoiesis
Yu, Z., Vromman, A., Nguyen, N. Q., Schuermans, A., Li, L., Rentz, T., Nakao, T., Vellarikkal, S. K., Uddin, M. M., Niroula, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66755-z · Cited by 17
AFM-based technologies as the way towards the reverse Avogadro number
Pleshakova, T. O., Shumov, I. D., Ivanov, Y. D., Malsagova, K. A., Kaysheva, A. L., & Archakov, A. I. (2015) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20156102239 · Cited by 12
Hshieh, T. T., Vasunilashorn, S. M., D’Aquila, M., Arnold, S. E., Dickerson, B. C., Fong, T. G., Jones, R. N., Marcantonio, E. R., Schmitt, E. M., Xu, G., et al. (2019) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.09.004 · Cited by 13
DNA methylation during human adipogenesis and the impact of fructose
Tini, G., Varma, V., Lombardo, R., Nolen, G. T., Lefebvre, G. C., Descombes, P., Métairon, S., Priami, C., Kaput, J., & Scott‐Boyer, M. (2020) · Genes & Nutrition · doi:10.1186/s12263-020-00680-2 · Cited by 12
Aptamer-Based Traceless Multiplexed Cell Isolation Systems
Cheng, E. L., Kacherovsky, N. A., & Pun, S. H. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c11783 · Cited by 12
Plasma proteome profiling identifies changes associated to AD but not to FTD
Mofrad, R. B., del Campo, M., Peeters, C. F. W., Meeter, L. H. H., Seelaar, H., Simmelink, M. J. A., Ramakers, I. H. G. B., Middelkoop, H. A. M., Deyn, P. P. D., Claassen, J. A. H. R., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01458-w · Cited by 13
Khan, M. A., Haider, N., Singh, T., Bandopadhyay, R., Ghoneim, M. M., Alshehri, S., Taha, M., Ahmad, J., & Mishra, A. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01180-z · Cited by 13
Osteitis is associated with dysregulated pro‐osteoblastic activity in patients with nasal polyps
Wu, D., Nocera, A. L., Mueller, S. K., Finn, K., Libermann, T. A., & Bleier, B. S. (2018) · The Laryngoscope · doi:10.1002/lary.27581 · Cited by 13
Modified aptamers as reagents to characterize recombinant human erythropoietin products
Jankowski, W., Lagassé, H. A. D., Chang, W. C., McGill, J. R., Jankowska, K. I., Gelinas, A. D., Janjić, N., & Sauna, Z. E. (2020) · Scientific Reports · doi:10.1038/s41598-020-75713-2 · Cited by 13
Ideal‐Filter Capillary Electrophoresis (IFCE) Facilitates the One‐Step Selection of Aptamers
Le, A. T. H., Krylova, S. M., Kanoatov, M., Desai, S. P., & Krylov, S. N. (2018) · Angewandte Chemie · doi:10.1002/ange.201812974 · Cited by 12
Hanly, P. J., Ahmed, S. B., Fjell, C. D., Handley, G. B., Sola, D. Y., Nicholl, D. D. M., & Zalucky, A. A. (2020) · Physiological Reports · doi:10.14814/phy2.14376 · Cited by 12
Using Aptamer-Based Technology to Probe the Plasma Proteome for Cardiovascular Disease Prediction
Sabatine, M. S. (2016) · JAMA · doi:10.1001/jama.2016.6110 · Cited by 12
An Inflammatory Clock Predicts Multi-morbidity, Immunosenescence and Cardiovascular Aging in HumansPreprint
Sayed, N., Gao, T., Tibshirani, R. J., Hastie, T. J., Cui, L., Kuznetsova, T., Rosenberg‐Hasson, Y., Ostan, R., Monti, D., Lehallier, B., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/840363 · Cited by 12
Goswami, P., & Chatterjee, S. (2025) · Clinical & Translational Oncology · doi:10.1007/s12094-025-04128-0 · Cited by 16
Bhatti, G., Romero, R. J., Gomez‐Lopez, N., Chaiworapongsa, T., Than, N. G., Theis, K. R., Galaz, J., Gotsch, F., Piqué-Regi, R., Berry, S. M., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-28157-3 · Cited by 12
Zhou, Y., Zheng, H., Tan, Z., Kang, E., Xue, P., Li, X., & Guan, F. (2024) · Journal of Chromatography B · doi:10.1016/j.jchromb.2024.124046 · Cited by 12
Exploring affinity chromatography in proteomics: A comprehensive review
Chamrád, I., Simerský, R., Lenobel, R., & Novák, O. (2024) · Analytica Chimica Acta · doi:10.1016/j.aca.2024.342513 · Cited by 15
Mid-life plasma proteins associated with late-life prefrailty and frailty: a proteomic analysis
Liu, F., Schrack, J. A., Walston, J. D., Mathias, R. A., Windham, B. G., Grams, M. E., Coresh, J., & Walker, K. A. (2024) · GeroScience · doi:10.1007/s11357-024-01219-8 · Cited by 15
Serum proteome signatures associated with liver steatosis in adolescents with obesity
Giraudi, P. J., Pascut, D., Banfi, C., Ghilardi, S., Tiribelli, C., Bondesan, A., Caroli, D., Minocci, A., & Sartório, A. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02419-x · Cited by 11
Star-shaped flexible arm multivalent aptamers for largely improved virus binding affinity
Simon, L., Szakács, Z., & Gyurcsányi, R. E. (2024) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2024.136520 · Cited by 11
Proteomic Assessment of the Risk of Secondary Cardiovascular Events among Individuals with CKD
Deo, R., Dubin, R. F., Ren, Y., Wang, J., Feldman, H. I., Shou, H., Coresh, J., Grams, M. E., Surapaneni, A., Cohen, J. B., et al. (2024) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000502 · Cited by 11
Choroid plexus apocrine secretion shapes CSF proteome during mouse brain development
Courtney, Y., Head, J. P., Dani, N., Chechneva, O. V., Shipley, F. B., Zhang, Y., Holtzman, M. J., Sadegh, C., Libermann, T. A., & Lehtinen, M. K. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-01972-9 · Cited by 26
Dreymann, N., Sabrowski, W., Danso, J., & Menger, M. (2022) · Cancers · doi:10.3390/cancers14215222 · Cited by 11
Using Artificial Intelligence to Better Predict and Develop Biomarkers
Michelhaugh, S. A., & Januzzi, J. L. (2023) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2022.09.021 · Cited by 16
Park, M., Kulkarni, A. R., Beatty, A. L., Ganz, P., Regan, M. C., Vittinghoff, E., & Whooley, M. A. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.10.092 · Cited by 11
DNA-based immunoassays for sensitive detection of protein
Akter, F., Mie, M., & Kobatake, E. (2014) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2014.05.135 · Cited by 12
Identification of novel systemic sclerosis biomarkers employing aptamer proteomic analysis
Wermuth, P. J., Piera-Velázquez, S., & Jiménez, S. A. (2017) · Rheumatology · doi:10.1093/rheumatology/kex404 · Cited by 12
Clinical Validation of a Protein Biomarker Panel for Non-Small Cell Lung Cancer
Jung, Y. J., Oh, I., Kim, Y., Jung, J. H., Seok, M., Lee, W., Park, C., Lim, J. H., Kim, Y., Kim, W., et al. (2018) · Journal of Korean Medical Science · doi:10.3346/jkms.2018.33.e342 · Cited by 11
Beloborodov, S. S., Krylova, S. M., & Krylov, S. N. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b02019 · Cited by 12
Shi, L., Buchanan, C. R., Cox, S. R., Hillary, R. F., Marioni, R. E., Campbell, A., Hayward, C., Stolicyn, A., Whalley, H. C., Harris, M. A., et al. (2021) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12240 · Cited by 10
Chemical Morphing of DNA Containing Four Noncanonical Bases
Eremeeva, E., Abramov, M., Margamuljana, L., Rozenski, J., Pezo, V., Marlière, P., & Herdewijn, P. A. (2016) · Angewandte Chemie · doi:10.1002/ange.201601529 · Cited by 11
Mass spectrometry-based biomarkers in drug development.
Miller, R. A., & Spellman, D. S. (2014) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-06068-2_16 · Cited by 13
Proteomic biomarkers of Kleine–Levin syndrome
Hedou, J. J., Cederberg, K. L. J., Ambati, A., Lin, L., Farber, N. M., Dauvilliers, Y. A., Quadri, M., Bourgin, P., Plazzi, G., Andlauer, O., et al. (2022) · SLEEP · doi:10.1093/sleep/zsac097 · Cited by 12
mTORC1-Dependent Protein and Parkinson’s Disease: A Mendelian Randomization Study
Tan, C., Ai, J., & Zhu, Y. (2023) · Brain Sciences · doi:10.3390/brainsci13040536 · Cited by 12
Breath Biomarkers and the Acute Respiratory Distress Syndrome
Crader, K. M., & Repine, J. D. (2012) · Journal of Pulmonary & Respiratory Medicine · doi:10.4172/2161-105x.1000111 · Cited by 13
Status and Prospects of Aptamers as Drug Components
Mattice, C., & DeRosa, M. C. (2015) · BioDrugs · doi:10.1007/s40259-015-0126-5 · Cited by 13
Characterization of Aptamer–Ligand Complexes
Miranda‐Castro, R., de-los-Santos-Álvarez, N., & Lobo-Castañón, M. J. (2018) · Wiley eBooks · doi:10.1002/9783527806799.ch4 · Cited by 13
Ikelaar, N. A., Barnard, A. M., Eng, S. W. M., Vajargah, S. H., Ha, K., Kan, H. E., Vandenborne, K., Niks, E. H., Walter, G. A., & Spitali, P. (2025) · Nature Communications · doi:10.1038/s41467-025-64146-y · Cited by 17
Evolution of Cross-Linking Aptamers for Long-Lasting Membrane Protein Labeling
Bian, S., Qiu, Q., Zhang, C., Cao, H., Xuan, H., Yan, X., Li, J., Chen, W., Liu, X., Chen, Y., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c16570 · Cited by 11
Self-citationEnhancement of in vivo targeting properties of ErbB2 aptamer by chemical modification
Park, J. Y., Cho, Y. L., Chae, J. R., Lee, J. H., & Kang, W. J. (2023) · PLoS ONE · doi:10.1371/journal.pone.0291624 · Cited by 10
Metadata
- Authors
- Gold, L., Ayers, D., Bertino, J., Bock, C., Bock, A., Brody, E. N., Carter, J., Dalby, A. B., Eaton, B. E., Fitzwater, T., Flather, D., Forbes, A., Foreman, T., Fowler, C., Gawande, B., Goss, M., Gunn, M., Gupta, S., Halladay, D., Heil, J., Heilig, J., Hicke, B., Husar, G., Janjic, N., Jarvis, T., Jennings, S., Katilius, E., Keeney, T. R., Kim, N., Koch, T. H., Kraemer, S., Kroiss, L., Le, N., Levine, D., Lindsey, W., Lollo, B., Mayfield, W., Mehan, M., Mehler, R., Nelson, S. K., Nelson, M., Nieuwlandt, D., Nikrad, M., Ochsner, U., Ostroff, R. M., Otis, M., Parker, T., Pietrasiewicz, S., Resnicow, D. I., Rohloff, J., Sanders, G., Sattin, S., Schneider, D., Singer, B., Stanton, M., Sterkel, A., Stewart, A., Stratford, S., Vaught, J. D., Vrkljan, M., Walker, J. J., Watrobka, M., Waugh, S., Weiss, A., Wilcox, S. K., Wolfson, A., Wolk, S. K., Zhang, C., & Zichi, D.
- Affiliations
- University of Colorado Boulder (US)
- SomaLogic (United States) (US)
- Cornell University (US)
- Corresponding author
- Gold, Larry
- Walker, Jeffrey J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-12-07
- Volume
- 5
- Issue
- 12
- Pages
- e15004
- ISSN
- 1756-0357 (ISSN-L)
- 1932-6203
- PMC
- PMC3000457
- OpenAlex
- W2084373725
- Cited by
- 1,754
- References
- 46
- Citations by year
- 2026: 164 · 2025: 190 · 2024: 170 · 2023: 154 · 2022: 184 · 2021: 127 · 2020: 115 · 2019: 105 · 2018: 95 · 2017: 98 · 2016: 78 · 2015: 73 · 2014: 60 · 2013: 56 · 2012: 50
- Type
- posted content
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Nature Precedings (publishedVersion, cc-by)
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Nature Precedings (submittedVersion)
- Funders
- University of Washington
- National Institutes of Health
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced biosensing and bioanalysis techniques
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced Biosensing Techniques and Applications
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Keywords
- aptamer-based proteomics, biomarker discovery, chemically modified nucleotides, DNA microarrays, plasma protein profiling, chronic kidney disease, multiplexed protein quantification, aptamer selection, disease biomarkers
- MeSH terms
- Aged, Female, Genetic Techniques, Glomerular Filtration Rate, Humans, Kidney Failure, Chronic, Kinetics, Male, Middle Aged, Nucleic Acid Hybridization, Mass Spectrometry, Reproducibility of Results, Biomarkers, Gene Library, Evidence-Based Medicine, Oligonucleotide Array Sequence Analysis, Proteome, Proteomics, Aptamers, Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.